Quantcast

Latest Microarrays Stories

2014-07-22 08:30:52

SAN DIEGO, July 22, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced its wholly owned subsidiary, Sequenom Laboratories, will soon begin reporting on the presence of three additional clinically relevant subchromosomal microdeletions as part of the Enhanced Sequencing Series (ESS) for its MaterniT21(TM) PLUS laboratory-developed test. The microdeletions added include 11q deletion (Jacobsen...

2014-07-18 23:02:44

Asia is poised to grow at the highest CAGR during the forecast period owing to support provided by foreign countries for enhancing forensics and DNA profiling services (http://www.marketsandmarkets.com/Market-Reports/human-identification-market-100607777.html). (PRWEB) July 18, 2014 The “Human Identification Market by Technology (Next Generation Sequencing, Rapid DNA Analysis, Capillary Electrophoresis, PCR), Application (Forensics, Paternity Testing), DNA Amplification, Quantification,...

2014-07-15 08:27:35

SAN DIEGO, July 15, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced it will report financial results for the second quarter of 2014 after closing of the NASDAQ Global Market on Tuesday, July 29, 2014. A conference call hosted by William Welch, Chief Executive Officer, and other members of senior management will take place on the same day at 5:00 p.m. EDT (2:00 p.m. PDT) and will be webcast...

2014-07-09 08:33:53

DUBLIN, July 9, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/nghblz/analysis_of) has announced the addition of the "Analysis of Global Biochips Industry, 2012-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Global biochips market is forecasted to reach US$11.4 billion by 2018 with a CAGR of 18.6% during 2012-2018; the massive CAGR is primarily supported by Asia-Pacific followed by the European Union. Among the major...

2014-06-20 12:23:10

DUBLIN, June 20, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/vcmqj4/gene_expression) has announced the addition of the "Global Gene Expression (DNA Microarray, Real-Time PCR, Next Generation Sequencing) Analysis Market - Forecast to 2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Over the years, the gene expression analysis market, comprising of instruments, consumables, and services, has witnessed various...

2014-06-19 08:28:14

SOPHIA ANTIPOLIS, France, and SAN DIEGO, June 19, 2014 /PRNewswire/ -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, and Sequenom, Inc. (NASDAQ:SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that Nicox's subsidiary, Nicox Inc. is launching expanded access to Sequenom Laboratories' RetnaGene(TM) portfolio of laboratory-developed genetic tests in the United States (U.S.). The RetnaGene portfolio includes...

2014-06-18 23:06:59

$3 Million NIH Grant to Fund Effort to Rescue Tissue That Would be Destroyed Charlottesville, Va. (PRWEB) June 18, 2014 The University of Virginia Health System has been awarded more than $3 million from the National Institutes of Health’s National Cancer Institute to support and expand a critically important program that makes tissue samples available for research on diseases ranging from breast cancer to lung disease. The five-year grant enables UVA to launch a partnership with...

2014-06-16 08:28:27

SAN DIEGO, June 16, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, announced today that it has received premarket 510(k) clearance from the United States Food and Drug Administration (FDA) to market its IMPACT Dx(TM) Factor V Leiden and Factor II Genotyping Test and the IMPACT Dx(TM) System. The IMPACT Dx Factor V Leiden and Factor II Genotyping Test is performed on the IMPACT Dx System, and is indicated...

2014-06-16 08:28:21

MADISON, N.J. and SAN DIEGO, June 16, 2014 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, and Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced an agreement under which Quest will offer national access to Sequenom Laboratories' MaterniT21(TM) PLUS laboratory-developed test (LDT). Using a maternal blood sample, the noninvasive prenatal test (NIPT)...

2014-06-16 04:21:39

IMPACT Dx(TM) Combined Function System Will Also Be Available in the European Union SAN DIEGO, June 16, 2014 /PRNewswire/ -- Agena Bioscience, Inc., which recently acquired the Bioscience business of Sequenom, Inc., was notified today by Sequenom, Inc. that it received premarket clearance from the U.S. Food and Drug Administration (FDA) for the IMPACT Dx(TM) Factor V Leiden and Factor II Genotyping Test and the IMPACT Dx(TM) System. The IMPACT Dx(TM) Factor V Leiden and Factor II...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related